PROTEIN BASED PHARMACEUTICAL TREATING

Brand Owner (click to sort) Address Description
APTICEL GENETICS INSTITUTE, INC. 87 CambridgePark Drive Cambridge MA 02140 protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system;
LERAKON GENETICS INSTITUTE, INC. 87 CambridgePark Drive Cambridge MA 02140 protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system;
TIVATOR GENETICS INSTITUTE, INC. 87 CambridgePark Drive Cambridge MA 02140 protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system;
XIIKIN GENETICS INSTITUTE, INC. 87 CambridgePark Drive Cambridge MA 02140 protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to a method for treating cancer using p38/JTV-1 and a method for screening pharmaceutical composition for treating cancer. More particularly, this invention relates to the method for treating cancer, which comprises administering the effective amount of p38/JTV-1 protein or a nucleic acid encoding for said protein to the patient and the method for screening a pharmaceutical composition for treating cancer characterized by selecting a substance having an effect on the increase of the activity of the p38/JTV-1 protein and the intracellular level thereof.